{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:50:05Z","timestamp":1790178605802,"version":"4.1.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,7,18]],"date-time":"2017-07-18T00:00:00Z","timestamp":1500336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1038\/bjc.2017.224","type":"journal-article","created":{"date-parts":[[2017,7,18]],"date-time":"2017-07-18T18:19:33Z","timestamp":1500401973000},"page":"826-834","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Novel immunohistochemistry-based signatures to predict metastatic site of triple-negative breast cancers"],"prefix":"10.1038","volume":"117","author":[{"given":"Sergey","family":"Klimov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padmashree CG","family":"Rida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed A","family":"Aleskandarany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian O","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiel AM","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad A","family":"Rakha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Aneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,18]]},"reference":[{"issue":"3","key":"BFbjc2017224_CR1","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/ijc.21004","volume":"116","author":"DM Abd El-Rehim","year":"2005","unstructured":"Abd El-Rehim DM, Ball G, Pinder SE, Rakha E, Paish C, Robertson JF, Macmillan D, Blamey RW, Ellis IO (2005) High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses. Int J Cancer 116 (3): 340\u2013350.","journal-title":"Int J Cancer"},{"issue":"2","key":"BFbjc2017224_CR2","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/path.1559","volume":"203","author":"DM Abd El-Rehim","year":"2004","unstructured":"Abd El-Rehim DM, Pinder SE, Paish CE, Bell J, Blamey RW, Robertson JF, Nicholson RI, Ellis IO (2004) Expression of luminal and basal cytokeratins in human breast carcinoma. J Pathol 203 (2): 661\u2013671.","journal-title":"J Pathol"},{"issue":"2","key":"BFbjc2017224_CR3","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s10549-015-3335-1","volume":"150","author":"R Abduljabbar","year":"2015","unstructured":"Abduljabbar R, Negm OH, Lai CF, Jerjees DA, Al-Kaabi M, Hamed MR, Tighe PJ, Buluwela L, Mukherjee A, Green AR, Ali S, Rakha EA, Ellis IO (2015) Clinical and biological significance of glucocorticoid receptor (GR) expression in breast cancer. Breast Cancer Res Treat 150 (2): 335\u2013346.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"BFbjc2017224_CR4","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s10549-014-2927-5","volume":"145","author":"MA Aleskandarany","year":"2014","unstructured":"Aleskandarany MA, Negm OH, Green AR, Ahmed MA, Nolan CC, Tighe PJ, Ellis IO, Rakha EA (2014) Epithelial mesenchymal transition in early invasive breast cancer: an immunohistochemical and reverse phase protein array study. Breast Cancer Res Treat 145 (2): 339\u2013348.","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"BFbjc2017224_CR5","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1038\/bjc.2015.165","volume":"112","author":"AT Alshareeda","year":"2015","unstructured":"Alshareeda AT, Negm OH, Green AR, Nolan CC, Tighe P, Albarakati N, Sultana R, Madhusudan S, Ellis IO, Rakha EA (2015) KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancer. Br J Cancer 112 (12): 1929\u20131937.","journal-title":"Br J Cancer"},{"key":"BFbjc2017224_CR6","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.3816\/CBC.2009.s.008","volume":"9","author":"CK Anders","year":"2009","unstructured":"Anders CK, Carey LA (2009) Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer. Clin Breast Cancer 9: S73\u2013S81.","journal-title":"Clin Breast Cancer"},{"issue":"12","key":"BFbjc2017224_CR7","first-page":"4028","volume":"5","author":"SM Arnold","year":"1999","unstructured":"Arnold SM, Young AB, Munn RK, Patchell RA, Nanayakkara N, Markesbery WR (1999) Expression of p53, bcl-2, E-cadherin, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinases-1 in paired primary tumors and brain metastasis. Clin Cancer Res 5 (12): 4028\u20134033.","journal-title":"Clin Cancer Res"},{"issue":"14","key":"BFbjc2017224_CR8","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1200\/JCO.2004.12.149","volume":"22","author":"JS Barnholtz-Sloan","year":"2004","unstructured":"Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE (2004) Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan detroit cancer surveillance system. J Clin Oncol 22 (14): 2865\u20132872.","journal-title":"J Clin Oncol"},{"key":"BFbjc2017224_CR9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1476-4598-7-36","volume":"7","author":"D Bernard-Gallon","year":"2008","unstructured":"Bernard-Gallon D, Bosviel R, Delort L, Fontana L, Chamoux A, Rabiau N, Kwiatkowski F, Chalabi N, Satih S, Bignon YJ (2008) DNA repair gene ERCC2 polymorphisms and associations with breast and ovarian cancer risk. Mol Cancer 7: 36.","journal-title":"Mol Cancer"},{"issue":"2","key":"BFbjc2017224_CR10","first-page":"139","volume":"3","author":"OL Bohn","year":"2009","unstructured":"Bohn OL, Nasir I, Brufsky A, Tseng GC, Bhargava R, MacManus K, Chivukula M (2009) Biomarker profile in breast carcinomas presenting with bone metastasis. Int J Clin Exp Pathol 3 (2): 139\u2013146.","journal-title":"Int J Clin Exp Pathol"},{"issue":"7249","key":"BFbjc2017224_CR11","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/nature08021","volume":"459","author":"PD Bos","year":"2009","unstructured":"Bos PD, Zhang XH-F, Nadal C, Shu W, Gomis RR, Nguyen DX, Minn AJ, van de Vijver MJ, Gerald WL, Foekens JA (2009) Genes that mediate breast cancer metastasis to the brain. Nature 459 (7249): 1005\u20131009.","journal-title":"Nature"},{"issue":"29","key":"BFbjc2017224_CR12","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1038\/onc.2011.41","volume":"30","author":"E Buache","year":"2011","unstructured":"Buache E, Etique N, Alpy F, Stoll I, Muckensturm M, Reina-San-Martin B, Chenard MP, Tomasetto C, Rio MC (2011) Deficiency in trefoil factor 1 (TFF1) increases tumorigenicity of human breast cancer cells and mammary tumor development in TFF1-knockout mice. Oncogene 30 (29): 3261\u20133273.","journal-title":"Oncogene"},{"key":"BFbjc2017224_CR13","first-page":"2879","volume":"12","author":"AD Bull","year":"2011","unstructured":"Bull AD (2011) Convergence rates of efficient global optimization algorithms. J Mach Learn Res 12: 2879\u20132904.","journal-title":"J Mach Learn Res"},{"issue":"3","key":"BFbjc2017224_CR14","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.breast.2012.03.003","volume":"21","author":"F Cardoso","year":"2012","unstructured":"Cardoso F, Costa A, Norton L, Cameron D, Cufer T, Fallowfield L, Francis P, Gligorov J, Kyriakides S, Lin N, Pagani O, Senkus E, Thomssen C, Aapro M, Bergh J, Di Leo A, El Saghir N, Ganz PA, Gelmon K, Goldhirsch A, Harbeck N, Houssami N, Hudis C, Kaufman B, Leadbeater M, Mayer M, Rodger A, Rugo H, Sacchini V, Sledge G, van\u2019t Veer L, Viale G, Krop I, Winer E (2012) 1st International consensus guidelines for advanced breast cancer (ABC 1). Breast 21 (3): 242\u2013252.","journal-title":"Breast"},{"issue":"11","key":"BFbjc2017224_CR15","doi-asserted-by":"publisher","first-page":"e1001699","DOI":"10.1371\/journal.pbio.1001699","volume":"11","author":"Timothy Caulfield","year":"2013","unstructured":"Caulfield T, Evans J, McGuire A, McCabe C, Bubela T, Cook-Deegan R, Fishman J, Hogarth S, Miller FA, Ravitsky V, Biesecker B, Borry P, Cho MK, Carroll JC, Etchegary H, Joly Y, Kato K, Lee SSJ, Rothenberg K, Sankar P, Szego MJ, Ossorio P, Pullman D, Rousseau F, Ungar WJ, Wilson B (2013) Reflections on the cost of \u2018low-cost\u2019 whole genome sequencing: framing the health policy debate. PLoS Biol 11 (11: e1001699).","journal-title":"PLoS Biology"},{"issue":"2","key":"BFbjc2017224_CR16","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nrc1276","volume":"4","author":"U Cavallaro","year":"2004","unstructured":"Cavallaro U, Christofori G (2004) Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 4 (2): 118\u2013132.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"BFbjc2017224_CR17","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1002\/1097-0215(200102)9999:9999<894::AID-IJC1146>3.0.CO;2-#","volume":"91","author":"WS Chen","year":"2001","unstructured":"Chen WS, Wei SJ, Liu JM, Hsiao M, Kou-Lin J, Yang WK (2001) Tumor invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase-2 (COX-2) expression and inhibited by a COX-2-selective inhibitor, etodolac. Int J Cancer 91 (6): 894\u2013899.","journal-title":"Int J Cancer"},{"issue":"5","key":"BFbjc2017224_CR18","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S1548-5315(11)70394-1","volume":"7","author":"DW Cleere","year":"2010","unstructured":"Cleere DW (2010) Triple-negative breast cancer: a clinical update. Commun Oncol 7 (5): 203\u2013211.","journal-title":"Commun Oncol"},{"issue":"Suppl 3","key":"BFbjc2017224_CR19","doi-asserted-by":"publisher","first-page":"iii124","DOI":"10.1093\/annonc\/mdu103","volume":"25","author":"R Coleman","year":"2014","unstructured":"Coleman R, Body JJ, Aapro M, Hadji P, Herrstedt J (2014) Bone health in cancer patients: ESMO clinical practice guidelines. Ann Oncol 25 (Suppl 3): iii124\u2013iii137.","journal-title":"Ann Oncol"},{"issue":"13","key":"BFbjc2017224_CR20","doi-asserted-by":"publisher","first-page":"3950","DOI":"10.1158\/1078-0432.CCR-05-2090","volume":"12","author":"E Dahl","year":"2006","unstructured":"Dahl E, Kristiansen G, Gottlob K, Klaman I, Ebner E, Hinzmann B, Hermann K, Pilarsky C, D\u00fcrst M, Klinkhammer-Schalke M, Blaszyk H, Knuechel R, Hartmann A, Rosenthal A, Wild PJ (2006) Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin \u03b12 as a potential novel prognostic marker in breast cancer. Clin Cancer Res 12 (13): 3950\u20133960.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"BFbjc2017224_CR21","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00428-007-0513-5","volume":"451","author":"A Dankof","year":"2007","unstructured":"Dankof A, Fritzsche FR, Dahl E, Pahl S, Wild P, Dietel M, Hartmann A, Kristiansen G (2007) KPNA2 protein expression in invasive breast carcinoma and matched peritumoral ductal carcinoma in situ. Virch Archiv 451 (5): 877\u2013881.","journal-title":"Virch Archiv"},{"issue":"6","key":"BFbjc2017224_CR22","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1158\/1078-0432.CCR-06-2854","volume":"13","author":"JF Deeken","year":"2007","unstructured":"Deeken JF, L\u00f6scher W (2007) The blood\u2013brain barrier and cancer: transporters, treatment, and trojan horses. Clin Cancer Res 13 (6): 1663\u20131674.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"BFbjc2017224_CR23","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/sj.bjc.6604463","volume":"99","author":"SE Elsheikh","year":"2008","unstructured":"Elsheikh SE, Green AR, Rakha EA, Samaka RM, Ammar AA, Powe D, Reis-Filho JS, Ellis IO (2008) Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype. Br J Cancer 99 (2): 327\u2013334.","journal-title":"Br J Cancer"},{"issue":"6","key":"BFbjc2017224_CR24","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrc1098","volume":"3","author":"IJ Fidler","year":"2003","unstructured":"Fidler IJ (2003) The pathogenesis of cancer metastasis: the \u2018seed and soil\u2019 hypothesis revisited. Nat Rev Cancer 3 (6): 453\u2013458.","journal-title":"Nat Rev Cancer"},{"key":"BFbjc2017224_CR25","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/BF01840834","volume":"22","author":"MH Galea","year":"1992","unstructured":"Galea MH, Blamey RW, Elston CW, Ellis IO (1992) The Nottingham Prognostic Index in primary breast cancer. Br Cancer Res Treat 22: 207\u2013219.","journal-title":"Br Cancer Res Treat"},{"key":"BFbjc2017224_CR26","unstructured":"Gelbart MA, Snoek J, Adams RP (2014) Bayesian optimization with unknown constraints. Preprint at https:\/\/arxiv.org\/abs\/1403.5607 ."},{"key":"BFbjc2017224_CR27","unstructured":"US Cancer Statistics Working Group (2016) United States Cancer Statistics: 1999-2013 Incidence and Mortality Web-Based Report. US Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute: Atlanta, GA, USA."},{"issue":"4","key":"BFbjc2017224_CR28","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","volume":"127","author":"GP Gupta","year":"2006","unstructured":"Gupta GP, Massagu\u00e9 J (2006) Cancer metastasis: building a framework. Cell 127 (4): 679\u2013695.","journal-title":"Cell"},{"key":"BFbjc2017224_CR29","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1101\/sqb.2005.70.018","volume":"70","author":"GP Gupta","year":"2005","unstructured":"Gupta GP, Minn AJ, Kang Y, Siegel PM, Serganova I, Cord\u00f3n-Cardo C, Olshen AB, Gerald WL, Massagu\u00e9 J (2005) Identifying site-specific metastasis genes and functions. Cold Spring Harb Symp Quant Biol 70: 149\u2013158.","journal-title":"Cold Spring Harb Symp Quant Biol"},{"issue":"49","key":"BFbjc2017224_CR30","doi-asserted-by":"publisher","first-page":"19506","DOI":"10.1073\/pnas.0709185104","volume":"104","author":"GP Gupta","year":"2007","unstructured":"Gupta GP, Perk J, Acharyya S, de Candia P, Mittal V, Todorova-Manova K, Gerald WL, Brogi E, Benezra R, Massagu\u00e9 J (2007) ID genes mediate tumor reinitiation during breast cancer lung metastasis. Proc Natl Acad Sci 104 (49): 19506\u201319511.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"BFbjc2017224_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10549-010-1161-z","volume":"129","author":"HO Habashy","year":"2011","unstructured":"Habashy HO, Rakha EA, Aleskandarany M, Ahmed MA, Green AR, Ellis IO, Powe DG (2011) FOXO3a nuclear localisation is associated with good prognosis in luminal-like breast cancer. Breast Cancer Res Treat 129 (1): 11\u201321.","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"BFbjc2017224_CR32","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1083\/jcb.148.4.779","volume":"148","author":"RB Hazan","year":"2000","unstructured":"Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA (2000) Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 148 (4): 779\u2013790.","journal-title":"J Cell Biol"},{"issue":"21","key":"BFbjc2017224_CR33","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.1200\/JCO.2003.08.017","volume":"21","author":"BE Hillner","year":"2003","unstructured":"Hillner BE, Ingle JN, Chlebowski RT, Gralow J, Yee GC, Janjan NA, Cauley JA, Blumenstein BA, Albain KS, Lipton A, Brown S (2003) American Society of Clinical Oncology 2003: update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol 21 (21): 4042\u20134057.","journal-title":"J Clin Oncol"},{"issue":"12","key":"BFbjc2017224_CR34","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/ncb1507","volume":"8","author":"S Hiratsuka","year":"2006","unstructured":"Hiratsuka S, Watanabe A, Aburatani H, Maru Y (2006) Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol 8 (12): 1369\u20131375.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"BFbjc2017224_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/jmcb\/mjp005","volume":"1","author":"G Hu","year":"2009","unstructured":"Hu G, Kang Y, Wang XF (2009) From breast to the brain: unraveling the puzzle of metastasis organotropism. J Mol Cell Biol 1 (1): 3\u20135.","journal-title":"J Mol Cell Biol"},{"issue":"2","key":"BFbjc2017224_CR36","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61 (2): 69\u201390.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"BFbjc2017224_CR37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10549-015-3308-4","volume":"150","author":"DA Jerjees","year":"2015","unstructured":"Jerjees DA, Negm OH, Alabdullah ML, Mirza S, Alkaabi M, Hameed MR, Abduljabbar R, Muftah A, Nolan CC, Green AR, Tighe PJ, Band V, Ellis IO, Rakha EA (2015) The mammalian target of rapamycin complex 1 (mTORC1) in breast cancer: the impact of oestrogen receptor and HER2 pathways. Breast Cancer Res Treat 150 (1): 91\u2013103.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"BFbjc2017224_CR38","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/pros.21240","volume":"71","author":"L Kai","year":"2011","unstructured":"Kai L, Wang J, Ivanovic M, Chung YT, Laskin WB, Schulze-Hoepfner F, Mirochnik Y, Satcher RL Jr, Levenson AS (2011) Targeting prostate cancer angiogenesis through metastasis-associated protein 1 (MTA1). Prostate 71 (3): 268\u2013280.","journal-title":"Prostate"},{"issue":"20","key":"BFbjc2017224_CR39","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1200\/JCO.2009.25.9820","volume":"28","author":"H Kennecke","year":"2010","unstructured":"Kennecke H, Yerushalmi R, Woods R, Cheang MCU, Voduc D, Speers CH, Nielsen TO, Gelmon K (2010) Metastatic behavior of breast cancer subtypes. J Clin Oncol 28 (20): 3271\u20133277.","journal-title":"J Clin Oncol"},{"issue":"1","key":"BFbjc2017224_CR40","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/01.nrl.0000106922.83090.71","volume":"10","author":"KJ Klos","year":"2004","unstructured":"Klos KJ, O\u2019Neill BP (2004) Brain metastases. Neurologist 10 (1): 31\u201346.","journal-title":"Neurologist"},{"key":"BFbjc2017224_CR41","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1053\/j.seminoncol.2003.08.005","volume":"30","author":"R Kumar","year":"2003","unstructured":"Kumar R, Wang R-A, Bagheri-Yarmand R (2003) Emerging roles of MTA family members in human cancers. Semin Oncol 30: 30\u201337.","journal-title":"Semin Oncol"},{"issue":"15","key":"BFbjc2017224_CR42","doi-asserted-by":"publisher","first-page":"6092","DOI":"10.1158\/0008-5472.CAN-08-0436","volume":"68","author":"T Landemaine","year":"2008","unstructured":"Landemaine T, Jackson A, Bellahc\u00e8ne A, Rucci N, Sin S, Abad BM, Sierra A, Boudinet A, Guinebreti\u00e8re J-M, Ricevuto E, Nogu\u00e8s C, Briffod M, Bi\u00e8che I, Cherel P, Garcia T, Castronovo V, Teti A, Lidereau R, Driouch K (2008) A six-gene signature predicting breast cancer lung metastasis. Cancer Res 68 (15): 6092\u20136099.","journal-title":"Cancer Res"},{"issue":"12","key":"BFbjc2017224_CR43","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1093\/annonc\/mdn424","volume":"19","author":"R Largillier","year":"2008","unstructured":"Largillier R, Ferrero JM, Doyen J, Barriere J, Namer M, Mari V, Courdi A, Hannoun-Levi JM, Ettore F, Birtwisle-Peyrottes I, Balu-Maestro C, Marcy PY, Raoust I, Lallement M, Chamorey E (2008) Prognostic factors in 1,038 women with metastatic breast cancer. Ann Oncol 19 (12): 2012\u20132019.","journal-title":"Ann Oncol"},{"issue":"3","key":"BFbjc2017224_CR44","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/jso.2930230311","volume":"23","author":"YTNM Lee","year":"1983","unstructured":"Lee YTNM (1983) Breast carcinoma: pattern of metastasis at autopsy. J Surg Oncol 23 (3): 175\u2013180.","journal-title":"J Surg Oncol"},{"issue":"8","key":"BFbjc2017224_CR45","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1200\/JCO.2007.14.4147","volume":"26","author":"C Liedtke","year":"2008","unstructured":"Liedtke C, Mazouni C, Hess KR, Andr\u00e9 F, Tordai A, Mejia JA, Symmans WF, Gonzalez-Angulo AM, Hennessy B, Green M, Cristofanilli M, Hortobagyi GN, Pusztai L (2008) Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol 26 (8): 1275\u20131281.","journal-title":"J Clin Oncol"},{"issue":"3","key":"BFbjc2017224_CR46","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.semcancer.2012.03.007","volume":"22","author":"G Lorusso","year":"2012","unstructured":"Lorusso G, Ruegg C (2012) New insights into the mechanisms of organ-specific breast cancer metastasis. Semin Cancer Biol 22 (3): 226\u2013233.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"BFbjc2017224_CR47","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.clon.2007.10.002","volume":"20","author":"AA Luck","year":"2008","unstructured":"Luck AA, Evans AJ, Green AR, Rakha EA, Paish C, Ellis IO (2008) The influence of basal phenotype on the metastatic pattern of breast cancer. Clin Oncol 20 (1): 40\u201345.","journal-title":"Clin Oncol"},{"issue":"3","key":"BFbjc2017224_CR48","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/S0002-9440(10)65628-3","volume":"153","author":"KJ Luzzi","year":"1998","unstructured":"Luzzi KJ, MacDonald IC, Schmidt EE, Kerkvliet N, Morris VL, Chambers AF, Groom AC (1998) Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 153 (3): 865\u2013873.","journal-title":"Am J Pathol"},{"issue":"15","key":"BFbjc2017224_CR49","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1200\/JCO.2010.30.5037","volume":"29","author":"SM Mahmoud","year":"2011","unstructured":"Mahmoud SM, Paish EC, Powe DG, Macmillan RD, Grainge MJ, Lee AH, Ellis IO, Green AR (2011) Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer. J Clin Oncol 29 (15): 1949\u20131955.","journal-title":"J Clin Oncol"},{"issue":"1","key":"BFbjc2017224_CR50","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1158\/1078-0432.CCR-13-1255","volume":"20","author":"D Malin","year":"2014","unstructured":"Malin D, Strekalova E, Petrovic V, Deal AM, Ahmad AA, Adamo B, Miller CR, Ugolkov A, Livasy C, Fritchie K, Hamilton E, Blackwell K, Geradts J, Ewend M, Carey L, Shusta EV, Anders CK, Cryns VL (2014) \u03b1B-crystallin: a novel regulator of breast cancer metastasis to the brain. Clin Cancer Res 20 (1): 56\u201367.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"BFbjc2017224_CR51","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1093\/annonc\/mdp411","volume":"21","author":"C Massard","year":"2010","unstructured":"Massard C, Zonierek J, Gross-Goupil M, Fizazi K, Szczylik C, Escudier B (2010) Incidence of brain metastases in renal cell carcinoma treated with sorafenib. Ann Oncol 21 (5): 1027\u20131031.","journal-title":"Ann Oncol"},{"key":"BFbjc2017224_CR52","unstructured":"Mandrekar JN, Mandrekar SJ, Cha SS (2003) Cutpoint Determination methods in Survival Analysis Using SAS. In Proceedings of the 28th SAS Users Group International (SUGI) Conference. pp 261\u2013288."},{"issue":"5","key":"BFbjc2017224_CR53","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.ejso.2006.02.009","volume":"32","author":"R Mihai","year":"2006","unstructured":"Mihai R, Stevens J, McKinney C, Ibrahim NBN (2006) Expression of the calcium receptor in human breast cancer\u2014a potential new marker predicting the risk of bone metastases. Eur J Surg Oncol 32 (5): 511\u2013515.","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"BFbjc2017224_CR54","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1172\/JCI22320","volume":"115","author":"AJ Minn","year":"2005","unstructured":"Minn AJ, Kang Y, Serganova I, Gupta GP, Giri DD, Doubrovin M, Ponomarev V, Gerald WL, Blasberg R, Massagu\u00e9 J (2005) Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Investig 115 (1): 44\u201355.","journal-title":"J Clin Investig"},{"issue":"8","key":"BFbjc2017224_CR55","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nrc867","volume":"2","author":"GR Mundy","year":"2002","unstructured":"Mundy GR (2002) Metastasis: Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2 (8): 584\u2013593.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"BFbjc2017224_CR56","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nrc2622","volume":"9","author":"DX Nguyen","year":"2009","unstructured":"Nguyen DX, Bos PD, Massague J (2009) Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 9 (4): 274\u2013284.","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"BFbjc2017224_CR57","doi-asserted-by":"publisher","first-page":"3761","DOI":"10.1158\/0008-5472.CAN-12-3998","volume":"73","author":"SB Pakala","year":"2013","unstructured":"Pakala SB, Rayala SK, Wang RA, Ohshiro K, Mudvari P, Reddy SDN, Zheng Y, Pires R, Casimiro S, Pillai MR, Costa L, Kumar R (2013) MTA1 promotes STAT3 transcription and pulmonary metastasis in breast cancer. Cancer Res 73 (12): 3761\u20133770.","journal-title":"Cancer Res"},{"issue":"19","key":"BFbjc2017224_CR58","doi-asserted-by":"publisher","first-page":"6148","DOI":"10.1158\/1078-0432.CCR-09-1039","volume":"15","author":"D Palmieri","year":"2009","unstructured":"Palmieri D, Lockman PR, Thomas FC, Hua E, Herring J, Hargrave E, Johnson M, Flores N, Qian Y, Vega-Valle E, Taskar KS, Rudraraju V, Mittapalli RK, Gaasch JA, Bohn KA, Thorsheim HR, Liewehr DJ, Davis S, Reilly JF, Walker R, Bronder JL, Feigenbaum L, Steinberg SM, Camphausen K, Meltzer PS, Richon VM, Smith QR, Steeg PS (2009) Vorinostat inhibits brain metastatic colonization in a model of triple-negative breast cancer and induces DNA double-strand breaks. Clin Cancer Res 15 (19): 6148\u20136157.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"BFbjc2017224_CR59","doi-asserted-by":"publisher","first-page":"160","DOI":"10.4048\/jbc.2015.18.2.160","volume":"18","author":"S Park","year":"2015","unstructured":"Park S, Han W, Kim J, Kim MK, Lee E, Yoo TK, Lee HB, Kang YJ, Kim YG, Moon HG, Noh DY (2015a) Risk factors associated with distant metastasis and survival outcomes in breast cancer patients with locoregional recurrence. J Breast Cancer 18 (2): 160\u2013166.","journal-title":"J Breast Cancer"},{"issue":"4","key":"BFbjc2017224_CR60","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.tranon.2015.04.004","volume":"8","author":"SH Park","year":"2015","unstructured":"Park SH, Noh SJ, Kim KM, Bae JS, Kwon KS, Jung SH, Kim JR, Lee H, Chung MJ, Moon WS, Kang MJ, Jang KY (2015b) Expression of DNA damage response molecules PARP1, \u03b3H2AX, BRCA1, and BRCA2 predicts poor survival of breast carcinoma patients. Transl Oncol 8 (4): 239\u2013249.","journal-title":"Transl Oncol"},{"issue":"2","key":"BFbjc2017224_CR61","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.tem.2007.10.003","volume":"19","author":"JK Perry","year":"2008","unstructured":"Perry JK, Kannan N, Grandison PM, Mitchell MD, Lobie PE (2008) Are trefoil factors oncogenic? Trends Endocrinol Metabol 19 (2): 74\u201381.","journal-title":"Trends Endocrinol Metabol"},{"issue":"1","key":"BFbjc2017224_CR62","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s12032-012-0388-4","volume":"30","author":"K Pogoda","year":"2013","unstructured":"Pogoda K, Niwi\u0144ska A, Murawska M, Pie\u0144kowski T (2013) Analysis of pattern, time and risk factors influencing recurrence in triple-negative breast cancer patients. Med Oncol 30 (1): 388\u2013396.","journal-title":"Med Oncol"},{"issue":"2","key":"BFbjc2017224_CR63","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1186\/bcr1384","volume":"8","author":"T Powles","year":"2006","unstructured":"Powles T, Paterson A, McCloskey E, Schein P, Scheffler B, Tidy A, Ashley S, Smith I, Ottestad L, Kanis J (2006) Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]. Breast Cancer Res 8 (2): R13.","journal-title":"Breast Cancer Res"},{"issue":"6","key":"BFbjc2017224_CR64","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1096\/fj.01-0498fje","volume":"16","author":"SJ Prest","year":"2002","unstructured":"Prest SJ, May FEB, Westley BR (2002) The estrogen-regulated protein, TFF1, stimulates migration of human breast cancer cells. FASEB J 16 (6): 592\u2013594.","journal-title":"FASEB J"},{"issue":"1","key":"BFbjc2017224_CR65","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/cncr.22381","volume":"109","author":"EA Rakha","year":"2007","unstructured":"Rakha EA, El-Sayed ME, Green AR, Lee AH, Robertson JF, Ellis IO (2007a) Prognostic markers in triple-negative breast cancer. Cancer 109 (1): 25\u201332.","journal-title":"Cancer"},{"issue":"1","key":"BFbjc2017224_CR66","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/cncr.22381","volume":"109","author":"EA Rakha","year":"2007","unstructured":"Rakha EA, El-Sayed ME, Green AR, Lee AHS, Robertson JF, Ellis IO (2007b) Prognostic markers in triple-negative breast cancer. Cancer 109 (1): 25\u201332.","journal-title":"Cancer"},{"issue":"7","key":"BFbjc2017224_CR67","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1158\/1078-0432.CCR-08-2132","volume":"15","author":"EA Rakha","year":"2009","unstructured":"Rakha EA, Elsheikh SE, Aleskandarany MA, Habashi HO, Green AR, Powe DG, El-Sayed ME, Benhasouna A, Brunet JS, Akslen LA, Evans AJ, Blamey R, Reis-Filho JS, Foulkes WD, Ellis IO (2009) Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes. Clin Cancer Res 15 (7): 2302\u20132310.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"BFbjc2017224_CR68","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/path.1916","volume":"208","author":"EA Rakha","year":"2006","unstructured":"Rakha EA, Putti TC, Abd El-Rehim DM, Paish C, Green AR, Powe DG, Lee AH, Robertson JF, Ellis IO (2006) Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation. J Pathol 208 (4): 495\u2013506.","journal-title":"J Pathol"},{"issue":"16","key":"BFbjc2017224_CR69","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1056\/NEJMra030831","volume":"350","author":"GD Roodman","year":"2004","unstructured":"Roodman GD (2004) Mechanisms of bone metastasis. N Engl J Med 350 (16): 1655\u20131664.","journal-title":"N Engl J Med"},{"key":"BFbjc2017224_CR70","doi-asserted-by":"crossref","unstructured":"Ruiz de Garibay G, Herranz C, Llorente A, Boni J, Serra-Musach J, Mateo F, Aguilar H, G\u00f3mez-Bald\u00f3 L, Petit A, Vidal A, Climent F, Hern\u00e1ndez-Losa J, Cordero \u00c1, Gonz\u00e1lez-Su\u00e1rez E, S\u00e1nchez-Mut J\u00e9 V, Esteller M, Llatj\u00f3s R, Varela M, L\u00f3pez J\u00e9 I, Garc\u00eda N, Extremera AI, Gum\u00e0 A, Ortega R, Pl\u00e0 M, Fern\u00e1ndez A, Pernas S, Falo C, Morilla I, Campos M, Gil M, Rom\u00e1n A, Molina-Molina M, Ussetti P, Laporta R, Valenzuela C, Ancochea J, Xaubet A, Casanova \u00c1, Pujana MA (2015) Lymphangioleiomyomatosis biomarkers linked to lung metastatic potential and cell stemness. PLoS ONE 10 (7).","DOI":"10.1371\/journal.pone.0132546"},{"issue":"4","key":"BFbjc2017224_CR71","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/jcb.240530417","volume":"53","author":"MS Sheikh","year":"1993","unstructured":"Sheikh MS, Shao Z-M, Chen J-C, Hussain A, Jetten AM, Fontana JA (1993) Estrogen receptor-negative breast cancer cells transfected with the estrogen receptor exhibit increased RAR\u03b1 gene expression and sensitivity to growth inhibition by retinoic acid. J Cell Biochem 53 (4): 394\u2013404.","journal-title":"J Cell Biochem"},{"issue":"15","key":"BFbjc2017224_CR72","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1200\/JCO.2005.03.8802","volume":"24","author":"M Smid","year":"2006","unstructured":"Smid M, Wang Y, Klijn JG, Sieuwerts AM, Zhang Y, Atkins D, Martens JW, Foekens JA (2006) Genes associated with breast cancer metastatic to bone. J Clin Oncol 24 (15): 2261\u20132267.","journal-title":"J Clin Oncol"},{"issue":"9","key":"BFbjc2017224_CR73","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1158\/0008-5472.CAN-07-5644","volume":"68","author":"M Smid","year":"2008","unstructured":"Smid M, Wang Y, Zhang Y, Sieuwerts AM, Yu J, Klijn JGM, Foekens JA, Martens JWM (2008) Subtypes of breast cancer show preferential site of relapse. Cancer Res 68 (9): 3108\u20133114.","journal-title":"Cancer Res"},{"issue":"9810","key":"BFbjc2017224_CR74","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0140-6736(11)61226-9","volume":"379","author":"MR Smith","year":"2012","unstructured":"Smith MR, Saad F, Coleman R, Shore N, Fizazi K, Tombal B, Miller K, Sieber P, Karsh L, Dami\u00e3o R, Tammela TL, Egerdie B, Van Poppel H, Chin J, Morote J, G\u00f3mez-Veiga F, Borkowski T, Ye Z, Kupic A, Dansey R, Goessl C (2012) Denosumab and bone metastasis-free survival in men with castration-resistant prostate cancer: results of a global phase 3, randomised, placebo-controlled trial. Lancet 379 (9810): 39\u201346.","journal-title":"Lancet"},{"issue":"4","key":"BFbjc2017224_CR75","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1007\/s13277-013-1461-0","volume":"35","author":"B Smolarz","year":"2014","unstructured":"Smolarz B, Makowska M, Samulak D, Michalska MM, Mojs E, Wilczak M, Romanowicz H (2014) Single nucleotide polymorphisms (SNPs) of ERCC2, hOGG1, and XRCC1 DNA repair genes and the risk of triple-negative breast cancer in Polish women. Tumour Biol 35 (4): 3495\u20133502.","journal-title":"Tumour Biol"},{"issue":"24","key":"BFbjc2017224_CR76","doi-asserted-by":"publisher","first-page":"13920","DOI":"10.1073\/pnas.96.24.13920","volume":"96","author":"BH Spain","year":"1999","unstructured":"Spain BH, Larson CJ, Shihabuddin LS, Gage FH, Verma IM (1999) Truncated BRCA2 is cytoplasmic: implications for cancer-linked mutations. Proc Natl Acad Sci USA 96 (24): 13920\u201313925.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"BFbjc2017224_CR77","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nrc3053","volume":"11","author":"PS Steeg","year":"2011","unstructured":"Steeg PS, Camphausen KA, Smith QR (2011) Brain metastases as preventive and therapeutic targets. Nat Rev Cancer 11 (5): 352\u2013363.","journal-title":"Nat Rev Cancer"},{"key":"BFbjc2017224_CR78","doi-asserted-by":"publisher","first-page":"15014","DOI":"10.1038\/npjbcancer.2015.14","volume":"1","author":"KD Voduc","year":"2015","unstructured":"Voduc KD, Nielsen TO, Perou CM, Harrell JC, Fan C, Kennecke H, Minn AJ, Cryns VL, Cheang MC (2015) [alpha] B-crystallin expression in breast cancer is associated with brain metastasis. npj Breast Cancer 1: 15014.","journal-title":"npj Breast Cancer"},{"issue":"26","key":"BFbjc2017224_CR79","doi-asserted-by":"publisher","first-page":"15901","DOI":"10.1073\/pnas.2634067100","volume":"100","author":"B Weigelt","year":"2003","unstructured":"Weigelt B, Glas AM, Wessels LFA, Witteveen AT, Peterse JL, van't Veer LJ (2003) Gene expression profiles of primary breast tumors maintained in distant metastases. Proc Natl Acad Sci USA 100 (26): 15901\u201315905.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"BFbjc2017224_CR80","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nrc1670","volume":"5","author":"B Weigelt","year":"2005","unstructured":"Weigelt B, Peterse JL, van't Veer LJ (2005) Breast cancer metastasis: markers and models. Nat Rev Cancer 5 (8): 591\u2013602.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"BFbjc2017224_CR81","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0002-9440(10)61180-7","volume":"167","author":"RJ Weil","year":"2005","unstructured":"Weil RJ, Palmieri DC, Bronder JL, Stark AM, Steeg PS (2005) Breast cancer metastasis to the central nervous system. Am J Pathol 167 (4): 913\u2013920.","journal-title":"Am J Pathol"},{"issue":"4","key":"BFbjc2017224_CR82","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s12253-015-9957-0","volume":"21","author":"P Winczura","year":"2015","unstructured":"Winczura P, Sosi\u0144ska-Mielcarek K, Duchnowska R, Badzio A, Lakomy J, Majewska H, P\u0119ksa R, Pieczy\u0144ska B, Radecka B, D\u0119bska-Szmich S, Adamowicz K, Biernat W, Jassem J (2015) Immunohistochemical predictors of bone metastases in breast cancer patients. Pathol Oncol Res 21 (4): 1229\u20131236.","journal-title":"Pathol Oncol Res"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2017224.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2017224","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/bjc.2017.224","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2017224.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:38:37Z","timestamp":1684417117000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2017224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,18]]},"references-count":82,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["BFbjc2017224"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2017.224","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,18]]},"assertion":[{"value":"13 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2017","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}